Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04670536
Other study ID # 0313
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date May 17, 2018
Est. completion date October 27, 2024

Study information

Verified date August 2023
Source Medicrea International
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this post-market clinical study is to evaluate the long-term safety and efficacy of the MEDICREA's systems PASS LP, PASS DEGEN, and PASS Tulip PRIME to treat degenerative diseases. This study is supporting the clinical evaluation report. From the standard-of-care perspective, the results of The Degen study are expected to contribute to a better understanding of expected safety and clinical outcomes from a short (intra- and peri-operative) to a medium-term follow-up (post-operatively).


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 75
Est. completion date October 27, 2024
Est. primary completion date October 27, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients of at least 18 years old - Patient suffering from a spinal degenerative disease. - Patient requiring spinal surgery for less than 4 levels for a spinal degenerative disease - Patient implanted with MEDICREA's products, or patients who are candidate to receive including at least the PASS LP and/or PASS DEGEN and/or PASS TULIP Prime implants - Patient affiliated to a national insurance system Exclusion Criteria: - Patient unable or unwilling to sign and understand an information note with proof of patient consent - Patient unable to complete a self-administered questionnaire - Patient presenting contra-indications to a Xray follow-up - Patient of more than 18 years old under a protection procedure - Patient judged as non-compliant by the investigator or not able to come back for follow-up visits up to 2 years

Study Design


Intervention

Device:
PASS LP implants
Thoraco lumbar arthrodesis
PASS DEGEN
Thoraco lumbar arthrodesis
PASS TULIP PRIME
Thoraco lumbar arthrodesis

Locations

Country Name City State
France Clinique du Dos Bordeaux - Terrefort Bruges
France Clinique des Cèdres Cornebarrieu
France CHRU Tours, Hôpital de Bretonneau Tours

Sponsors (1)

Lead Sponsor Collaborator
Medicrea International

Country where clinical trial is conducted

France, 

References & Publications (9)

Copay AG, Glassman SD, Subach BR, Berven S, Schuler TC, Carreon LY. Minimum clinically important difference in lumbar spine surgery patients: a choice of methods using the Oswestry Disability Index, Medical Outcomes Study questionnaire Short Form 36, and pain scales. Spine J. 2008 Nov-Dec;8(6):968-74. doi: 10.1016/j.spinee.2007.11.006. Epub 2008 Jan 16. — View Citation

Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine (Phila Pa 1976). 2000 Nov 15;25(22):2940-52; discussion 2952. doi: 10.1097/00007632-200011150-00017. — View Citation

Fairbank JC. Why are there different versions of the Oswestry Disability Index? J Neurosurg Spine. 2014 Jan;20(1):83-6. doi: 10.3171/2013.9.SPINE13344. Epub 2013 Nov 8. — View Citation

Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998 Nov;51(11):1171-8. doi: 10.1016/s0895-4356(98)00109-7. — View Citation

Ghogawala Z, Whitmore RG, Watters WC 3rd, Sharan A, Mummaneni PV, Dailey AT, Choudhri TF, Eck JC, Groff MW, Wang JC, Resnick DK, Dhall SS, Kaiser MG. Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 3: assessment of economic outcome. J Neurosurg Spine. 2014 Jul;21(1):14-22. doi: 10.3171/2014.4.SPINE14259. — View Citation

Glassman SD, Carreon LY, Djurasovic M, Dimar JR, Johnson JR, Puno RM, Campbell MJ. Lumbar fusion outcomes stratified by specific diagnostic indication. Spine J. 2009 Jan-Feb;9(1):13-21. doi: 10.1016/j.spinee.2008.08.011. Epub 2008 Sep 19. — View Citation

Gum JL, Carreon LY, Stimac JD, Glassman SD. Predictors of Oswestry Disability Index worsening after lumbar fusion. Orthopedics. 2013 Apr;36(4):e478-83. doi: 10.3928/01477447-20130327-26. — View Citation

Hagg O, Fritzell P, Nordwall A; Swedish Lumbar Spine Study Group. The clinical importance of changes in outcome scores after treatment for chronic low back pain. Eur Spine J. 2003 Feb;12(1):12-20. doi: 10.1007/s00586-002-0464-0. Epub 2002 Oct 24. — View Citation

Johnsen LG, Hellum C, Nygaard OP, Storheim K, Brox JI, Rossvoll I, Leivseth G, Grotle M. Comparison of the SF6D, the EQ5D, and the oswestry disability index in patients with chronic low back pain and degenerative disc disease. BMC Musculoskelet Disord. 2013 Apr 26;14:148. doi: 10.1186/1471-2474-14-148. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Fusion The primary endpoint is the fusion status of each patient at the 24-month visit postoperative. This fusion assessment will be done through the analysis of the standard of care imaging (CT-scan, X-rays, and/or MRI) by the investigator and through the clinical examination of the patient by the investigator. At 24months
Secondary Evolution of the pain (VAS) Change of leg and back pain score from the preoperative visit to all available postoperative timepoints: from 0 (better) to 10 (worst) Preoperative, and 1-6, 12 and 24 months postoperative
Secondary Quality of life with ODI Change of non-validated ODI score from the preoperative visit to all available postoperative timepoints: from 0 (better) to 5 (worst) Preoperative, and 1-6, 12 and 24 months postoperative
Secondary Quality of life with SF-12 Change of non-validated SF-12 score from the preoperative visit to all available postoperative timepoints: from to 0 (better) to 3 or 5 depending the question (worst) Preoperative, and 1-6, 12 and 24 months postoperative
Secondary Device or procedure-related adverse events and all SAEs up to 24 months During the follow-up period, the occurrence of device and procedure related AEs and all serious adverse events will be monitored, registered, and analyzed. To safeguard the safety of the clinical study subjects, all SAEs will be collected even those that may not be directly related to the surgery. Preoperative, and 1-6, 12 and 24 months postoperative
Secondary Surgeons'satisfaction with these implants and instruments Surgeons will be requested to complete questions about device/surgery satisfaction. During the surgery and until the 24months postoperative visit
Secondary Fusion status at the 1/6 month and 12-month visit The primary objective is defined as the ability of the implant to promote the stabilization At the 1-6, and 12 months postoperative
Secondary Patient satisfaction at all available postoperative timepoints Patient satisfaction is used to evaluate patient satisfaction after surgery and during the follow-up period.
Satisfaction is measured at four different levels: 1 (better) to 4 (worst)
At 1-6, 12 and 24 months postoperative
See also
  Status Clinical Trial Phase
Completed NCT01220505 - Post Market Surveillance to Evaluate the Effectiveness the Polaris Deformity Spinal System
Terminated NCT00974623 - Bone Graft Materials Observational Registry N/A
Withdrawn NCT02058238 - ADDRESS - Adult Deformity Robotic vs. Freehand Surgery to Correct Spinal Deformity
Recruiting NCT05323448 - Efficacy of ARISTA-AH for Restoring Hemostasis Following Posterior Long-segment Spinal Fusion. N/A
Recruiting NCT05108948 - Research of Factors Determining the Improvement of Quality of Life at One Year of Adult Patients Treated for Spinal Deformity (COFTASD)
Completed NCT02950532 - Posterior Ligament Complex Assessment Without Magnetic Resonance Image in Thoracolumbar Fractures
Completed NCT01982045 - RCT of AttraX® Putty vs. Autograft in Instrumented Posterolateral Spinal Fusion N/A
Active, not recruiting NCT00738439 - Prospective, Multi-Center Adult Spinal Deformity Outcomes Database Registry
Completed NCT05579834 - Hemothorax Caused by Posterior Correction Surgery for Spinal Deformity
Completed NCT01608854 - Comparison of Antibiotic Protocols in Spine Patients With Postoperative Drains N/A
Active, not recruiting NCT04899297 - Quality of Life in Parents of Adolescents With Spinal Deformities: Development of a New Questionnaire.
Completed NCT05239962 - A Reliability And Validity Study Of The Urdu Version Of Spine Functional Index.
Active, not recruiting NCT05001893 - Clinical Safety and Efficacy of S53P4 Bioactive Glass Putty in Spinal Fusion Surgery
Completed NCT01601054 - Supplemental Anterior Lumbar Interbody Fusion (ALIF) in Spinal Deformity N/A
Completed NCT03880292 - Spinal Deformity Intraoperative Monitoring. N/A
Recruiting NCT05856370 - The Ailliance Post-Market Clinical Study N/A
Recruiting NCT05146193 - AI-Powered Scoliosis Auto-Analysis System Multicenter Development and Validations
Active, not recruiting NCT04642456 - Balance Assessment Scale and Strength Measurement Protocol to Measure Functionality in Adults With Spinal Deformity N/A
Recruiting NCT04071665 - A Modified Lateral Lumbar Interbody Fusion VS. Transforaminal Lumbar Interbody Fusion for Adult Degenerative Scoliosis N/A
Completed NCT06009601 - The Relationship Between Pectus Deformities and Spinal Pathologies